October 2020 Volume 6, Issue 12

October 2020

Volume 6, Issue 12

This issue examines racism in the U.S. health care system, discusses the FDA’s newly loosened blood donation restrictions, and more.

Table of Contents

October 2020 Issue

Editor’s Corner: Move Over Millennials: Time to Teach Outside the Boundaries

Thursday, October 1st, 2020
The many meanings and purposes of the word “zoom” and its namesake technology are especially relevant in today’s educational environment. To prepare our educators,...
You Make the Call

Reader Responses: Is 3 months of anticoagulation enough for a provoked VTE?

Thursday, October 1st, 2020
Here’s how readers responded to a You Make the Call question about the appropriate length of anticoagulation for a provoked DVT. Disclaimer: ASH does not...

A Day in the Life: Blood, Sweat, and Smears

Thursday, October 1st, 2020
In our newest series, hematologists working in a variety of settings provide a glimpse into their daily lives. In this edition, Megan Nakashima, MD, peeks out...

October 2020 Issue

WIB_icon

Is Post-Discharge VTE Prophylaxis Necessary for Patients With COVID-19?

Thursday, October 1st, 2020
In hospitalized patients with COVID-19, the risk of venous thromboembolism (VTE) following discharge was not significantly greater compared with the VTE risk in patients...

Oliceridine Approved for Management of Acute Pain

Thursday, October 1st, 2020
Oliceridine, a parenterally administered μ-receptor opioid agonist, is approved for the management of moderate to severe acute pain in adults requiring an intravenous (IV)...

New “Buy American” Order Mandates Domestic Manufacturing of Essential Drugs

Thursday, October 1st, 2020
President Donald Trump signed a new executive order requiring that certain “essential” drugs and medical supplies purchased by the federal government be manufactured in...

FDA Approves Belantamab Mafodotin-blmf for Relapsed/Refractory Multiple Myeloma

Thursday, October 1st, 2020
Belantamab mafodotin-blmf, an anti–B-cell maturation antigen (BCMA) antibody-drug conjugate therapy, received accelerated approval for the treatment of adults with relapsed or refractory multiple myeloma...

Tafasitamab-cxix Receives Accelerated Approval for Relapsed/Refractory DLBCL

Thursday, October 1st, 2020
The FDA granted accelerated approval to tafasitamab-cxix in combination with lenalidomide for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma...
WIB_icon

Mavorixafor Mobilizes White Blood Cells in Patients With WHIM Syndrome

Thursday, October 1st, 2020
Long-term treatment with once-daily oral mavorixafor, an inhibitor of CXCR4, reduced the number of cutaneous warts and infections and effectively increased neutrophil and lymphocyte...
WIB_icon

Short Telomere Length Increases Non-Relapse Mortality Risk After Allogeneic Transplant for MDS

Thursday, October 1st, 2020
According to research published in Blood, shorter telomere length was an independent risk factor for non-relapse mortality (NRM) and overall survival (OS) in patients...

Evaluating Post-Transplant Sorafenib Maintenance in FLT3-Mutated AML

Thursday, October 1st, 2020
For patients with acute myeloid leukemia (AML) and an FLT3-ITD mutation, maintenance treatment with the multitargeted tyrosine kinase inhibitor (TKI) sorafenib significantly prolonged relapse-free...
ASH Directions

Diversity, Equity, and Inclusion in Hematology, and more

Thursday, October 1st, 2020
Diversity, Equity, and Inclusion in Hematology ASH is committed to building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and...
WIB_icon

IVIg and Rituximab-Based Regimens Are the Most Effective Treatments for CANOMAD Syndrome

Thursday, October 1st, 2020
Approximately one-third of patients with CANOMAD (chronic ataxic neuropathy, ophthalmoplegia, immunoglobulin M paraprotein, cold agglutinins, and disialosyl antibodies) syndrome have a hematologic malignancy,...
WIB_icon

Is Haploidentical Better Than Cord Blood Transplantation in Leukemia and Lymphoma?

Thursday, October 1st, 2020
Allogeneic hematopoietic cell transplantation with cord blood or haploidentical bone marrow extend access to transplantation for patients who lack a human leukocyte antigen (HLA)–matched...
The Society Pages

NCI Partners with Cancer Research UK, JADPRO Appoints Beth Faiman as Editor-in-Chief, and more

Thursday, October 1st, 2020
Fred Hutchinson Researchers Receive $3.5-Million Grant for Inherited Blood Disorder Treatment Hans-Peter Kiem, MD, PhD, and Roland Walter, MD, PhD, from the Fred Hutchinson Cancer...
WIB_icon

Small Retrospective Study Suggests Thrombopoietin Receptor Agonists Are Safe, Likely Effective for ITP During...

Thursday, October 1st, 2020
Preliminary findings from an observational multicenter study suggest that temporary off-label use of thrombopoietin receptor agonists (TPO-RAs) for the treatment of severe and/or refractory...

Inhaled Vaporized Cannabis Yields No Analgesic Benefit in Patients With SCD

Thursday, October 1st, 2020
Inhalation of vaporized cannabis did not significantly reduce self-reported pain levels or disease-related symptoms in adults with sickle cell disease (SCD) compared with placebo,...

October 2020 Issue

Racism Persists in Medicine, Including Hematology

Thursday, October 1st, 2020
Medicine is not exempt from the explicit and implicit racism seen in other parts of American life. When Deirdra Terrell, PhD, MPH, started attending...

Pulling Back the Curtain: Moshe Mittelman, MD

Thursday, October 1st, 2020
In this edition, Moshe Mittelman, MD, describes growing up in a newly established State of Israel, his military service, and how both experiences affected...
Blood donation

Rewriting the Rules of Blood Donation

Thursday, October 1st, 2020
What will the FDA’s newly loosened blood donation restrictions mean for donors, blood banks, and the safety of the national blood supply? In the initial...

October 2020 Issue

You Make the Call

You Make the Call: Is 3 months of anticoagulation enough for a provoked VTE?

Thursday, October 1st, 2020
This month, Keith McCrae, MD, discusses the appropriate length of anticoagulation for a provoked DVT. And don't forget to check out next month's clinical dilemma...

How I Teach: Navigating the COVID Classroom

Thursday, October 1st, 2020
As the COVID-19 pandemic increased rapidly in the U.S. in March and April 2020, the Association of American Medical Colleges (AAMC) released guidance strongly...